Edition:
United States

Tissue Regenix Group PLC (TRX.L)

TRX.L on London Stock Exchange

15.50GBp
24 Mar 2017
Change (% chg)

0.00 (+0.00%)
Prev Close
15.50
Open
15.50
Day's High
--
Day's Low
--
Volume
148,339
Avg. Vol
285,648
52-wk High
22.00
52-wk Low
15.00

Latest Key Developments (Source: Significant Developments)

Tissue Regenix Group Plc announces additional US regional distribution agreement
Wednesday, 22 Jul 2015 02:00am EDT 

Tissue Regenix Group Plc:Says announces that TRX Wound Care Inc. has signed an additional regional distribution agreement for DermaPure.This agreement has been signed with an experienced local surgical and wound care distributor who will cover one of the 12 states in the Novitas Medicare administrative jurisdiction.Partnership is expected to be worth minimum of $135k over the next 12 months and follows signing of first regional distributor agreement, covering two states in the jurisdiction, which is expected to be worth minimum of $600k over next 12 months.Signing of this agreement is representative of the significant, and growing, commercial interest in DermaPure after what has been transformational year for product.  Full Article

Tissue Regenix Group signs US regional distribution agreement
Tuesday, 5 May 2015 02:02am EDT 

Tissue Regenix Group:Says that TRX Wound Care Inc. has signed a new regional distribution contract for DermaPure which is used in the treatment of chronic and acute wounds.  Full Article

Tissue Regenix Group announces OrthoPureT XT (Tendon) UK clinical trial approval
Tuesday, 28 Apr 2015 02:01am EDT 

Tissue Regenix Group:Announces it has secured approval from the Medicines and Healthcare Products Regulatory Agency for the first clinical trial of its decellularised.  Full Article

More From Around the Web

BRIEF-Tissue Regenix Group names new group finance director

* Appointment of Paul Devlin as group finance director and company secretary with immediate effect Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)